Intermediate Name | Structure | Code | CAS Number | API/ END USE |
N,N-Dimethyl-3-phenyl-3-(O-tolyloxy)propan-1-amine oxalate | DPPO-3 | 107688-86-8 | Atomoxetine | |
(R)-3-Amino-piperidine dihydrochloride | CNOP-6 | 334618-23-4 | Alogliptin Linagliptin Trelagliptin | |
(R)-3-(Boc-Amino)piperidine | BCN-4 | 309956-78-3 | Alogliptin Linagliptin Trelagliptin | |
2-(Chloromethyl)-4-methylquinazoline | CMQ-1 | 109113-72-6 | Alogliptin Linagliptin Trelagliptin | |
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine | BBX-2 | 666816-98-4 | Alogliptin Linagliptin Trelagliptin | |
3-(Dimethylamino)-1-(naphthalen-1-yl)propan-1-one hydrochloride | BDQ-1 | 5409-58-5 | Bedaquiline | |
3-Benzyl-6-bromo-2-methoxyquinoline | BBM-3 | 654655-69-3 | Bedaquiline | |
Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl)butanoate | DAM-3 | 3543-72-4 | Bendamustine | |
Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2-yl)butanoate | DAM-4 | 3543-73-5 | Bendamustine | |
5-iodo-2-methylbenzoic acid | IMB-1 | 54811-38-0 | Canagliflozin | |
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene | ICG-2 | 898566-17-1 | Canagliflozin | |
2,3,4,6-tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone | CDE-1 | 32384-65-9 | Canagliflozin Dapagliflozin Empagliflozin |
|
4-chloro-6,7-dimethoxyquinoline | CAB-4 | 35654-56-9 | Cabozantinib | |
4- Guanidinobenzoic Acid HCl | GBA HCl | 42823-46-1 | Camostat mesylate | |
2-Chloro-N,N-dimethylacetamide | CST-1 | 2675-89-0 | Camostat mesylate | |
4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester | CST-2 | 59721-16-3 | Camostat mesylate | |
3-(3-Trifluoromethylphenyl)propionic Acid | TPA-2 | 585-50-2 | Cinacalcet | |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide | CNC | 1005450-55-4 | Cinacalcet | |
4-(4-Chlorophenyl)-1H-benzo[D][1,2]oxazin-1-one | CLT-1 | 2224-83-1 | Chlorthalidone | |
3-(4'-chlorophenyl) phthalimidine | CLT-2 | 2224-77-3 | Chlorthalidone | |
4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene | BDG-2 | 461432-23-5 | Dapagliflozin | |
1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene | IDG-2 | 1103738-29-9 | Dapagliflozin | |
N-(2-Hydroxyethyl) succinimide | HDS-1 | 18190-44-8 | Diroximel fumarate | |
3,4-Dibenzyloxybenzaldehyde | DBZ | 5447-02-09 | Droxidopa | |
2-ethoxybenzo[d][1,3]dioxole-5-carbaldehyde | DXP-1 | 1638296-86-2 | Droxidopa | |
Ethyl 3(-4-(ethyl amino)-3- nitro-N-(pyridin-2-yl)benzamido)propanoate | DG-2 | 429659-01-8 | Dabigatran | |
Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate | CBA-3G | 212322-56-0 | Dabigatran | |
2-(4-Cyanophenylamino) Acetic Acid | CBA-4 | 42288-26-6 | Dabigatran | |
Ethyl-3-[[[2-[[(4-cyanophenyl) amino] methyl]-1methyl-1H-benzimidazol-5-yl]carbonyl]pyridine-2-ylamino] propionate. | DBG-1 | 211915-84-3 | Dabigatran | |
Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride. | DBG-2 | 211914-50-0 | Dabigatran | |
ethyl 3-[[2-(chloromethyl)-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate | DAB-1 | 1307233-94-8 | Dabigatran | |
Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl) phenyl) amino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d] imidazole-5-carboxamido) propanoate | DAB-2 | 211915-06-9 | Dabigatran | |
Hexyl ((4-aminophenyl)(imino)methyl)carbamate hydrochloride | NAR-2 | 1307233-93-7 | Dabigatran | |
2-(N-BOC)-Aminothiazole-5-carboxylic acid | DTB-3 | 302964-02-9 | Dasatinib | |
(E)-N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide | ATC-2 | 863127-76-8 | Dasatinib | |
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | ATC-3 | 302964-24-5 | Dasatinib | |
4,6-dichloro-2-methylpyrimidine | PMD-2 | 1780-26-3 | Dasatinib | |
N-Boc-D-phenyl glycinol | RPG-2 | 102089-74-7 | Elagolix | |
(R)-2-(tert-butoxycarbonylamino)-2-phenylethyl methanesulfonate | RPG-3 | 102089-75-8 | Elagolix | |
2,3-dihydrobenzo[b][1,4]dioxine-6-carbaldehyde | DBD | 29668-44-8 | Eliglustat | |
(S)-(+)-2-Phenylglycinol | ELG | 20989-17-7 | Eliglustat | |
5-Bromo-2-chlorobenzoic acid | BEB-3 | 21739-92-4 | Empagliflozin | |
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran | BEG-3 | 915095-89-5 | Empagliflozin | |
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydrofuran | IEG-3 | 915095-94-2 | Empagliflozin | |
6,7-Dihydro-9,10-dimethoxy-2-[(2,4,6-trimethylphenyl)amino]-4H-pyrimido[6,1-a]isoquinolin-4-one | ENS-4 | 76536-66-8 | Ensifentrine | |
3-(N-Methyl-N-Pentyl amino)propionic acid HCl | IBA3 | 625120-81-2 | Ibandronate | |
4-Aminopyrazolo[3,4-d]pyrimidine | IBT-3P | 2380-63-4 | Ibrutinib | |
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | PPA-2 | 330786-24-8 | Ibrutinib | |
(ethane-1,2-diylbis(oxy)) bis(ethane-2,1-diyl) bis(4-methylbenzenesulfonate) | ICT-1 | 19249-03-7 | Icotinib | |
4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride | MPB-2 | 106261-49-8 | Imatinib | |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | IMA-5 | 152460-10-1 | Imatinib | |
Ethyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate | IVF-2 | 52980-28-6 | Ivacaftor | |
4-oxo-1,4-dihydroquinoline-3-carboxylic acid (USDMF No. 33616) | IVF-3P | 13721-01-2 | Ivacaftor | |
5-Amino-2,4-ditert-butylphenol | ABT-3 | 873055-58-4 | Ivacaftor | |
5-Amino-2,4-ditert-butylphenol hydrochloride | ABT-4 | 1777786-05-6 | Ivacaftor | |
2-bromo-1-(2,4-dichlorophenyl)ethanone | DCA | 2631-72-3 | Levoketocazole | |
(S)-4-Chloromethyl-2,2-dimethyl-1,3-dioxolane | SKL | 60456-22-6 | Levoketocazole | |
4-Chloro-1-(4-fluorophenyl)butan-1-one | LMT-1 | 3874-54-2 | Lumateperone | |
2-(2-Aminothiazol-4-yl)acetic acid | ATA-2 | 29676-71-9 | Mirabegron | |
2-(2-Aminothiazol-4-yl)acetic acid hydrochloride | ATA-2 HCL | 66659-20-9 | Mirabegron | |
2-(4-nitrophenyl)ethanamine hydrochloride | MRG-2 | 29968-78-3 | Mirabegron | |
(R)-2-(4-nitrophenethylamino)-1- Phenylethanol (USDMF No 35841 ) | MRG-4 BASE | 223673-34-5 | Mirabegron | |
(R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride | MRG-4 | 521284-21-9 | Mirabegron | |
(R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | MRG-5 BASE | 391901-45-4 | Mirabegron | |
(R)-2-(4-aminophenethylamino)-1-Phenylethanol hydrochloride | MRG-5 | 521284-22-0 | Mirabegron | |
N-Hydroxycytidine acetonide ester | MLP-1 | 2346620-55-9 | Molnupiravir | |
1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one | MCZ | 27387-31-1 | Ondansetron | |
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride | MAN | 119812-29-2 | Ondansetron | |
L-Glutamic acid diethyl ester hydrochloride | GDE | 1118-89-4 | Pemetrexed disodium | |
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid | PEM-7 | 137281-39-1 | Pemetrexed disodium | |
4-(6-Fluoro-1,2-benzisoxazole-3yl)-Piperidine Hydrochloride | PRSI-4 | 84163-13-3 | Paliperidone Risperidone | |
4-[2,4-Difluoro benzoyl]Piperidine hydrochloride | PLP-2H | 106266-04-0 | Paliperidone Risperidone | |
3-(Benzyloxy)pyridine-2-amine | POL-1 | 24016-03-3 | Paliperidone Risperidone | |
3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrididine-4-one | SPR2Base | 63234-80-0 | Paliperidone Risperidone | |
2-Benzyl acrylic acid | RAC-2 | 5669-19-2 | Racecadotril | |
Benzyl glycinate p-toluene sulfonate | RAC-3 | 1738-76-7 | Racecadotril | |
3-Amino-6-methoxy pyridazine | AMP-2 | 7252-84-8 | Relugolix | |
Isonipecotamide /4-Piperidinecarboxamide | INA | 39546-32-2 | Revefenacin | |
Phenyl phenylcarbamate | RPT-1 | 4930-03-4 | Ripretinib | |
(R)-4-chloro-N-(2-hydroxy-3-(4-(3-oxomorpholino)phenylamino)propyl) cyclopenta-1,3- dienecarboxamide | RIV-3 | 721401-53-2 | Rivaroxaban | |
2-[(2S)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione | RXB-1 | 1369969-44-7 | Rivaroxaban | |
2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione | RXB-2 | 446292-08-6 | Rivaroxaban | |
(S)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | RXB-3 | 898543-06-1 | Rivaroxaban | |
Methane sulfonamide | CMS-1 | 3144-09-0 | Selexipag | |
4-(Isopropylamino)butan-1-ol | BBA-2 | 42042-71-7 | Selexipag | |
1,2,4-Triazolo[4,3-a]pyrazine, 5,6,7,8-tetrahydro-3-(trifluoromethyl) hydrochloride | DST | 762240-92-6 | Sitagliptin | |
4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one | SITA-2 | 764667-65-4 | Sitagliptin | |
(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine | SITA-3 | 767340 -03 -4 | Sitagliptin | |
3-Quinuclidinone hydrochloride | RCN-2 | 1193-65-3 | Solifenacin | |
4-[2-hydroxyethyl]phenol | TRS-2 | 501-94-0 | Tyrosol | |
4-chloro-7H-pyrrolo [2,3-d]pyrimidine | ITF-3 | 3680-69-1 | Tofacitinib Barcitinib Ruxolitinib | |
4-Bromo-7H pyrrolo[2,3D]pyrimidine | ITB-3 | 889939-42-8 | Tofacitinib Barcitinib Ruxolitinib | |
2,4-Dichloro-1H-pyrrolo[2,3-D]pyrimidine | TDC | 90213-66-4 | Tofacitinib Barcitinib Ruxolitinib | |
3-Cyclopentylacrylonitrile | CPA | 591769-05-0 | Tofacitinib Barcitinib Ruxolitinib | |
1,4,7-Trimethyl-1,4,7-Triazacyclononane | TMT4 | 96556-05-7 | Others | |
BOC-L-Glutamine | NBG | 13726-85-7 | Others | |
(S)-Dimethyl 2-((tert-butoxycarbonyl)amino)pentanedioate | BGM-2 | 59279-60-6 | Others | |
1-Methylpiperidine-4-carboxamide | MPC-2 | 62718-28-9 | Others | |
1-methylpiperidine-4-carbonitrile | MPC-3 | 20691-92-3 | Others | |
(1-Methylpiperidin-4-yl)Methanamine | MPC-4 | 7149-42-0 | Others |
Note: All Transactions are carried out in conformity with patent laws applicable in the buyer’s country.
Responsibility with respect to third parties’ patent rights in a specific country lies exclusively with the buyer. Mail to: marketing@arlifesciences.com